FDA daily for Saturday, June 27, 2026
In this issue: 1 approval, 1 device decision and 16 label changes.
Drug and biologic approvals
FDA date:On Sat, Jun 20 FDA approved no new applications and 1 supplement to existing ones.
- METFORMIN HYDROCHLORIDE
CHARTWELL · METFORMIN HYDROCHLORIDE
Device clearances and approvals
FDA date:FDA decided 1 510(k) and 0 PMA decisions on Sat, Jun 13.
- Enobio Dx (Enobio Dx 8);Enobio Dx (Enobio Dx 20);Enobio Dx (Enobio Dx 32)
Neuroelectrics Barcelona S.L.U. · Neurology
Label updates
FDA date:16 drug labels took effect on Sat, Jun 13.
Browse label updates in FDA data →How the FDA daily is written
Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug and device recalls, and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Complete response letters appear the day after FDA publishes a batch.
Subscribe with any feed reader, or point an email tool at the RSS feed to send each issue as a newsletter. Search any drug, device or company across every FDA dataset in the FDA data explorer.
